ARYA Sciences Acquisition Corp II
51 Astor Place, 10th Floor
New York, New York 10003
June 2, 2020
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attention: Ruairi Regan
|
Re:
|
ARYA Sciences Acquisition Corp II
|
|
|
Registration Statement on Form S-1
|
|
|
File No. 333-238488
|
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, ARYA Sciences Acquisition Corp II (the “Company”) hereby requests
acceleration of the effective date of the above referenced Registration Statement to 4:00 p.m., Eastern Time, on June 4, 2020, or as soon thereafter as practicable, or at such other time as the Company or its outside counsel, Kirkland & Ellis
LLP, request by telephone that such Registration Statement be declared effective.
Please contact Christian O. Nagler, of Kirkland & Ellis LLP, special counsel to the Company, at (212) 446-4660, as soon as the Registration
Statement has been declared effective, or if you have any other questions or concerns regarding this matter.
|
Sincerely,
|
|
|
|
/s/ Adam Stone
|
|
Adam Stone
|
|
Chief Executive Officer
|
Cerevel is now part of AbbVie
Together we will deliver science that takes us closer to meaningful change for people with neurological and psychiatric disorders.
Read the press release